m+Medelevator.RU
← Поиск публикаций
Cancer medicine · 2026

A Pilot Feasibility Study of a Group-Based Remote-Delivered Dyadic Exercise Intervention in Hispanic Men With Prostate Cancer and Their Caregivers.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Skiba Meghan B, Contreras Juan, Nelson Marjorie A, Recio-Boiles Alejandro, Garcia David O, Chilton Floyd H, Segrin Chris, Badger Terry A, Winters-Stone Kerri M

Аннотация

PURPOSE: The purpose of this study was to determine the feasibility and acceptability of a Hispanic adapted culturally relevant Exercising Together© intervention (HACER) through a single-arm pilot in post-treatment Hispanic men with prostate cancer and their caregivers.

METHODS: Dyads participated together in a live, remote group-based 12-week exercise intervention with resistance training three times a week. Primary outcomes were intervention feasibility and acceptability. Secondary outcomes were measures of physical and psychosocial health. Assessments were completed at baseline and post-intervention. Mean difference and effect sizes were calculated to determine intervention effects.

RESULTS: Accrual of eligible dyads was 75%. Fourteen eligible dyads were allocated to intervention. Attendance averaged 62%. Retention was 79% with 95% assessment completion. Participants rated HACER as acceptable and 86% would recommend the program to other dyads. Self-reported physical activity level and objective physical function improved for survivors and caregivers, with clinically significant improvement in caregiver depressive symptoms.

CONCLUSIONS: HACER was feasible and acceptable with modest improvements in physical and psychosocial health, especially for Hispanic survivors. HACER shows promise as a scalable intervention to improve health outcomes for Hispanic cancer survivors and caregivers when they train together; a larger, fully powered efficacy trial is warranted.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты